JUNS · Jupiter Neurosciences Inc
United States · RS rating 97 · As of 2026-11-03
| Price | 2.43 USD |
|---|---|
| 1-day change | +5.2% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 58 / 99 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 26 / 39 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +9.3% |
| Sales growth Q/Q | -14.4% |
| Distance from 52-week high | +60.8% |
| Market cap (USD) | $14.0M |